IL41527A - Timed release pharmaceutical compositions comprising propoxyphene napsylate - Google Patents
Timed release pharmaceutical compositions comprising propoxyphene napsylateInfo
- Publication number
- IL41527A IL41527A IL41527A IL4152773A IL41527A IL 41527 A IL41527 A IL 41527A IL 41527 A IL41527 A IL 41527A IL 4152773 A IL4152773 A IL 4152773A IL 41527 A IL41527 A IL 41527A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- release pharmaceutical
- timed release
- propoxyphene napsylate
- propoxyphene
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22792072A | 1972-02-22 | 1972-02-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL41527A0 IL41527A0 (en) | 1973-04-30 |
| IL41527A true IL41527A (en) | 1975-12-31 |
Family
ID=22854980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL41527A IL41527A (en) | 1972-02-22 | 1973-02-13 | Timed release pharmaceutical compositions comprising propoxyphene napsylate |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US3758679A (xx) |
| JP (1) | JPS4896716A (xx) |
| AR (1) | AR195704A1 (xx) |
| AT (1) | AT330360B (xx) |
| AU (1) | AU473502B2 (xx) |
| BE (1) | BE795766A (xx) |
| CA (1) | CA1016460A (xx) |
| DD (1) | DD102302A5 (xx) |
| DE (1) | DE2307747A1 (xx) |
| ES (1) | ES411946A1 (xx) |
| FR (1) | FR2181747B1 (xx) |
| GB (1) | GB1390311A (xx) |
| HU (1) | HU165913B (xx) |
| IE (1) | IE37297B1 (xx) |
| IL (1) | IL41527A (xx) |
| NL (1) | NL7302385A (xx) |
| SE (1) | SE382751B (xx) |
| ZA (1) | ZA731154B (xx) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3922339A (en) * | 1974-06-20 | 1975-11-25 | Kv Pharm Co | Sustained release medicant |
| US4167558A (en) | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
| GB1561204A (en) * | 1977-06-01 | 1980-02-13 | Ici Ltd | Sustained release pharmaceutical composition |
| DE2923279B1 (de) * | 1979-06-08 | 1980-11-20 | Kali Chemie Pharma Gmbh | Verfahren zur Herstellung von Pankreatin-Pellets |
| US4665100A (en) * | 1981-03-13 | 1987-05-12 | Eli Lilly And Company | Process for formulating a synthetic drug for use in animal feed, and resulting formulation |
| JPS615027A (ja) * | 1984-06-18 | 1986-01-10 | Sadahiro Nakano | 徐放性固形製剤 |
| GB8518927D0 (en) * | 1985-07-26 | 1985-09-04 | Vincent Processes Ltd | Tablets |
| US5198226A (en) * | 1986-01-30 | 1993-03-30 | Syntex (U.S.A.) Inc. | Long acting nicardipine hydrochloride formulation |
| IL81419A0 (en) * | 1986-01-30 | 1987-08-31 | Syntex Inc | Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation |
| US4940556A (en) * | 1986-01-30 | 1990-07-10 | Syntex (U.S.A.) Inc. | Method of preparing long acting formulation |
| US4855143A (en) * | 1986-04-04 | 1989-08-08 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
| US4775535A (en) * | 1986-04-04 | 1988-10-04 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
| DE3612211A1 (de) * | 1986-04-11 | 1987-10-15 | Basf Ag | Kontinuierliches verfahren zum tablettieren |
| GB8624213D0 (en) * | 1986-10-09 | 1986-11-12 | Sandoz Canada Inc | Sustained release pharmaceutical compositions |
| US5443764A (en) * | 1987-07-01 | 1995-08-22 | Ici Australia Operations Propietary Limited | Water-dispersible granules |
| IT1227336B (it) * | 1987-09-11 | 1991-04-08 | Squibb & Sons Inc | Composizione farmaceutica contenente un carico elevato di medicamento e procedimento per la sua preparazione |
| US4973470A (en) * | 1989-06-26 | 1990-11-27 | Warner-Lambert Company | Sustained release pharmaceutical compositions |
| GB2264639B (en) * | 1992-02-20 | 1996-05-22 | Euro Celtique Sa | Modified Release Formulation |
| GB9203689D0 (en) * | 1992-02-20 | 1992-04-08 | Euro Celtique Sa | Pharmaceutical composition |
| US5837292A (en) * | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
| GB2418854B (en) * | 2004-08-31 | 2009-12-23 | Euro Celtique Sa | Multiparticulates |
| US20080057122A1 (en) * | 2006-08-31 | 2008-03-06 | Aaipharma Inc. | Acetaminophen pharmaceutical compositions |
-
0
- BE BE795766D patent/BE795766A/xx unknown
-
1972
- 1972-02-22 US US00227920A patent/US3758679A/en not_active Expired - Lifetime
-
1973
- 1973-02-13 IL IL41527A patent/IL41527A/xx unknown
- 1973-02-15 AU AU52223/73A patent/AU473502B2/en not_active Expired
- 1973-02-16 DE DE19732307747 patent/DE2307747A1/de active Pending
- 1973-02-16 FR FR7305651A patent/FR2181747B1/fr not_active Expired
- 1973-02-16 GB GB779073A patent/GB1390311A/en not_active Expired
- 1973-02-19 ZA ZA731154A patent/ZA731154B/xx unknown
- 1973-02-19 IE IE257/73A patent/IE37297B1/xx unknown
- 1973-02-19 CA CA163,998A patent/CA1016460A/en not_active Expired
- 1973-02-20 SE SE7302330A patent/SE382751B/xx unknown
- 1973-02-21 NL NL7302385A patent/NL7302385A/xx not_active Application Discontinuation
- 1973-02-21 AR AR246705A patent/AR195704A1/es active
- 1973-02-21 HU HUEI465A patent/HU165913B/hu unknown
- 1973-02-21 AT AT151973A patent/AT330360B/de not_active IP Right Cessation
- 1973-02-22 DD DD168994A patent/DD102302A5/xx unknown
- 1973-02-22 ES ES411946A patent/ES411946A1/es not_active Expired
- 1973-02-22 JP JP48021701A patent/JPS4896716A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US3758679A (en) | 1973-09-11 |
| GB1390311A (en) | 1975-04-09 |
| BE795766A (fr) | 1973-08-22 |
| FR2181747A1 (xx) | 1973-12-07 |
| AU5222373A (en) | 1974-08-15 |
| IE37297B1 (en) | 1977-06-22 |
| FR2181747B1 (xx) | 1976-12-31 |
| AT330360B (de) | 1976-06-25 |
| AU473502B2 (en) | 1976-06-24 |
| NL7302385A (xx) | 1973-08-24 |
| AR195704A1 (es) | 1973-10-31 |
| HU165913B (xx) | 1974-12-28 |
| JPS4896716A (xx) | 1973-12-10 |
| ES411946A1 (es) | 1976-05-01 |
| ATA151973A (de) | 1975-09-15 |
| IL41527A0 (en) | 1973-04-30 |
| DD102302A5 (xx) | 1973-12-12 |
| CA1016460A (en) | 1977-08-30 |
| IE37297L (en) | 1973-08-22 |
| ZA731154B (en) | 1974-10-30 |
| DE2307747A1 (de) | 1973-08-30 |
| SE382751B (sv) | 1976-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL41527A (en) | Timed release pharmaceutical compositions comprising propoxyphene napsylate | |
| ZA731808B (en) | Pharmaceutical compositions | |
| HK41078A (en) | Pharmaceutical composition | |
| ZA733406B (en) | Pharmaceutical formulations | |
| AU475599B2 (en) | Pharmaceutical compositions | |
| ZA731012B (en) | Pharmaceutical compositions | |
| ZA732439B (en) | Pharmaceutical composition | |
| KE2807A (en) | Pharmaceutical formulations | |
| AU5915973A (en) | Pharmaceutical compositions | |
| ZA734331B (en) | Pharmaceutical compositions | |
| AU471794B2 (en) | Iodophor-steroid pharmaceutical compositions | |
| CA1006816A (fr) | Compositions pharmaceutiques | |
| MY7900236A (en) | Pharmaceutical wypolipidemic compositions | |
| AU5207873A (en) | Pharmaceutical compositions | |
| ZA735099B (en) | Pharmaceutical composition | |
| AU6063773A (en) | Pharmaceutical compositions | |
| CA907518A (en) | Medicinal compositions | |
| CA910906A (en) | Pharmaceutical compositions | |
| CA894211A (en) | Pharmaceutical compositions | |
| AU472192B2 (en) | Pharmaceutical compositions | |
| CA892542A (en) | Pharmaceutical compositions | |
| CA907516A (en) | Pharmaceutical compositions | |
| AU474663B2 (en) | Pharmaceutical compositions | |
| CA896528A (en) | Pharmaceutical compositions | |
| CA899777A (en) | Pharmaceutical compositions |